ISIS Pharmaceuticals Inc

Visual Financials
Company Name: ISIS Pharmaceuticals Inc
Ticker Symbol: ISIS
CIK Number: 0000874015
WWW Address: http://www.isispharm.com
CEO: Dr. Stanley T. Crooke,M.D.,PhD
No. of Employees: 390
Common Issue Type: CS
Business Description:Isis Pharmaceuticals is engaged in antisense drug discovery and development, exploiting a novel drug discovery platform it created to generate a broad pipeline of first-in-class drugs.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 57.56 Unchanged 0.0 - -  58.45 56.70 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 6,914.0 120.1 0.00 -0.33 0.00 0.0 0.0 77.80 - 37.38
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close57.57$
PE Ratio - LTM0.0
Market Capitalisation6,914.0mil
Latest Shares Outstanding120.1mil
Earnings pS (EPS)-0.33$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee549,131$
Effective Tax Rate0.0%
Float100.8mil
Float as % of Shares Outstanding0.8%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.10%
Research & Devlopment (R&D) as % of Revenue1.10%
Gross Profit Margin100.0%
EBITDA Margin-10.6%
Pre-Tax Profit Margin0.0%
Assets Turnover23.8%
Return on Assets (ROA)-4.3%
Return on Equity (ROE)-12.3%
Return on Capital Invested (ROCI)-4.2%
Current Ratio7.3
Leverage Ratio (Assets/Equity)3.7
Interest Cover-1.4
Total Debt/Equity (Gearing Ratio)1.78
LT Debt/Total Capital64.0%
Working Capital pS6.00$
Cash pS0.00$
Book-Value pS2.04$
Tangible Book-Value pS1.98$
Cash Flow pS1.08$
Free Cash Flow pS0.98$
KEY FIGURES (LTM): Price info
Price/Book Ratio28.33
Price/Tangible Book Ratio0.00
Price/Cash Flow53.5
Price/Free Cash Flow59.2
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.0-21,098,459
4 Weeks0.000.000.000.0-1
13 Weeks63.7152.0661.30-6.111,081,13425,947,226
26 Weeks65.3437.3851.3312.1221,603,996142,755,703
52 Weeks77.8037.3863.43-9.31,936,529420,226,811
YTD0.000.00-0.06
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
57.8857.0457.0452.1057.130.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.120.50.29
Income0.0
Dividend0.0
Capital SpendingNA
R&D10.70NA4.93
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %86.686.63.0
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.220.220.20
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio75.46
Current Ratio7.3
Quick Ratio (Acid Test)6.4
Liquidity Ratio (Cash)7.56
Receivables Turnover28.5
Average Collection Period13
Working Capital/Equity279.8
Working Capital pS6.06
Cash-Flow pS0.05
Free Cash-Flow pS-0.04
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio6.91
Financial Leverage Ratio (Assets/Equity)1.8
Debt Ratio47.9
Total Debt/Equity (Gearing Ratio)1.78
LT Debt/Equity1.76
LT Debt/Capital Invested81.4
LT Debt/Total Liabilities99.4
Interest Cover-1.4
Interest/Capital Invested2.64
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio7.27
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-297.38
Enterprise Value (EV)/Free Cash Flow-1,305.24
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM28.33
Price/Cash Flow Ratio53.5
Price/Free Cash Flow Ratio - LTM59.2
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio652.9
5-Y Low P/E Ratio52.4
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E35
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS4.54
Current Liabilities pS1.15
Tangible Book Value pS - LTM1.98
Book Value pS - LTM2.04
Capital Invested pS5.96
Cash pS - LTM0.00
Cash Flow pS - LTM1.08
Free Cash Flow pS - LTM0.98
Earnings pS (EPS)-0.33
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-2.25
Free Cash Flow Margin 5YEAR AVG-33.56
Net Profit Margin-0.2
Net Profit Margin - 5YEAR AVRG.-0.5
Equity Productivity0.83
Return on Equity (ROE)-0.1
Return on Equity (ROE) - 5YEAR AVRG.-0.3
Capital Invested Productivity0.30
Return on Capital Invested (ROCI)-0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.1
Assets Productivity0.20
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.-0.1
Gross Profit Margin100.0
Gross Profit Margin - 5YEAR AVRG.1.0
EBITDA Margin - LTM-10.6
EBIT Margin - LTM-15.0
Pre-Tax Profit Margin-0.6
Pre-Tax Profit Margin - 5YEAR AVRG.-0.6
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.1.7
EFFICIENCY RATIOS
Cash Conversion Cycle305,239
Revenue per Employee549,131
Net Income per Employee
Average Collection Period305,239
Receivables Turnover28.5
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales2.9
Accounts Payble/Sales8.40
Assets/Revenue5.00
Net Working Capital Turnover0.30
Fixed Assets Turnover1.80
Total Assets Turnover0.2
Revenue per $ Cash1.50
Revenue per $ Plant2.41
Revenue per $ Common Equity0.83
Revenue per $ Capital Invested0.30
Selling, General & Adm/tive (SG&A) as % of Revenue9.4
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue112.9
R&D Expense as % of Revenue - 5YEAR AVRG.112.9

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.